Metafolate Tablet is a combination medication formulated to support glycemic control and address associated metabolic and neurological conditions. It contains Metformin 500 mg, a widely used biguanide antihyperglycemic agent that improves insulin sensitivity and reduces hepatic glucose production, thereby aiding in the management of type 2 diabetes mellitus. The inclusion of L-Methyl Folate 0.5 mg, the bioactive form of folate, facilitates enhanced folate metabolism, which is crucial for DNA synthesis, repair, and methylation processes. Methylcobalamin (750 mcg), an active form of vitamin B12, supports neurological function and helps prevent peripheral neuropathy commonly seen in diabetic patients. Myo-Inositol 550 mg, a naturally occurring carbocyclic sugar, plays a significant role in insulin signal transduction and ovarian function, potentially benefiting metabolic and reproductive health. This fixed-dose combination aims to provide comprehensive management by not only controlling blood glucose levels but also addressing micronutrient deficiencies and neurological complications associated with diabetes. Metafolate Tablet should be used under medical supervision, with dosage adjustments based on individual patient needs and clinical response. It is contraindicated in patients with renal impairment, hypersensitivity to any component, or conditions predisposing to lactic acidosis.